Theravance Biopharma, Inc. Reports First Quarter 2022 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to Theravance Biopharma, Inc. Reports First Quarter 2022 Financial Results and Provides Business Update

Theravance Biopharma (TBPH) Misses Q1 EPS by 23c

May 5, 2022 5:22 PM EDT

Theravance Biopharma (NASDAQ: TBPH) reported Q1 EPS of ($0.34), $0.23 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $13.2 million versus the consensus estimate of $14.48 million.

Cash, cash equivalents and marketable securities totaled $147.5 million as of March 31, 2022.

For earnings history and... More